ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420961 | Rec_0433619 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM T lymphoid cells |
0.31 ± 0.07 μg/mL | IC50 (p25 ELISA; graded virus-dose series) |
12610147 | - |
YES |
| 420962 | Rec_0433620 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM T lymphoid cells |
0.92 ± 0.05 μg/mL | IC50 (p25 ELISA; graded virus-dose series) |
12610147 | - |
YES |
| 420963 | Rec_0433621 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM T lymphoid cells |
2.02 ± 0.1 μg/mL | IC50 (p25 ELISA; graded virus-dose series) |
12610147 | - |
YES |
| 420964 | Rec_0433622 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM cells; preincubation: buffer control |
0.04 ± 0.02 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420965 | Rec_0433623 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM cells; preincubation: AT2-inactivated virions alone |
0.03 ± 0.01 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420966 | Rec_0433624 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM cells; preincubation: MBM cells alone |
0.08 ± 0.03 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420967 | Rec_0433625 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM cells; preincubation: AT2 virions plus MBM cells; adsorption without entry |
>1 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420968 | Rec_0433626 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-M2; MBM cells; preincubation: AT2 virions plus MBM cells; entry allowed |
0.04 ± 0.03 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420969 | Rec_0433627 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-GL8; MBM cells; preincubation: buffer control |
0.46 ± 0.10 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420970 | Rec_0433628 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-GL8; MBM cells; preincubation: AT2-inactivated virions alone |
0.77 ± 0.20 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420971 | Rec_0433629 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-GL8; MBM cells; preincubation: MBM cells alone |
0.38 ± 0.03 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420972 | Rec_0433630 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-GL8; MBM cells; preincubation: AT2 virions plus MBM cells; adsorption without entry |
>1 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420973 | Rec_0433631 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-GL8; MBM cells; preincubation: AT2 virions plus MBM cells; entry allowed |
0.46 ± 0.13 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420974 | Rec_0433632 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-Pet; MBM cells; preincubation: buffer control |
0.03 ± 0.02 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420975 | Rec_0433633 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-Pet; MBM cells; preincubation: AT2-inactivated virions alone |
>1 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420976 | Rec_0433634 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-Pet; MBM cells; preincubation: MBM cells alone |
0.06 ± 0.04 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420977 | Rec_0433635 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-Pet; MBM cells; preincubation: AT2 virions plus MBM cells; adsorption without entry |
>1 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420978 | Rec_0433636 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
Antiviral |
Feline immunodeficiency virus FIV-Pet; MBM cells; preincubation: AT2 virions plus MBM cells; entry allowed |
0.03 ± 0.01 μg/mL | Residual antiviral IC50 (p25 ELISA; preincubation assay) |
12610147 | - |
YES |
| 420979 | Rec_0433637 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
- |
MBM T lymphoid cells |
- | Cell viability and proliferation |
12610147 | - |
YES |
| 420980 | Rec_0433638 | C8 |
WEDWVGWI |
synthetic construct [Synthetic] |
- |
DMSO/water and phosphate-buffer solution |
- | Circular dichroism; solution NMR |
12610147 | - |
YES |